drugset / Trial / NCT06889064

A Study to Evaluate the Pharmacokinetic, Pharmacodynamic Characteristics and the Safety After Administration by Doses of BR1400-1, BR1400-2, BR1400-3 in Healthy Adult Volunteers

NCT06889064 ↗

Phase 1 Completed 28 enrolled Boryung Pharmaceutical Co., Ltd
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this clinical study is to evaluate the pharmacokinetic, pharmacodynamic characteristics and the safety after administration by doses of "BR1400-1", "BR1400-2", "BR1400-3" in healthy volunteers

Timeline

Start
2024-09-24
Primary completion
2024-10-08
Completion
2024-10-08

Drugs

EvaluationDrugModalityDoseRoute
Subject BR1400-1 Unknown — —
Subject BR1400-2 Unknown — —
Subject BR1400-3 Unknown — —